Table I.
Primer | Sequence (5′-3′) | Product length (bps) |
---|---|---|
Wnt-1 | Forward: GGTGGGGCATCGTGAACATAG | 296 |
Reverse: GGAGGTGATTGCGAAGATAAACG | ||
GSK-3β | Forward: ATGCCTGTCTCCTCTAACGC | 321 |
Reverse: GGTCTTGGTGGCGGGTTT | ||
β-catenin | Forward: GCTGACCAAACTGCTAAATGACGA | 192 |
Reverse: TGTAGGGTCCCAGCGGTACAA | ||
NF-κB | Forward: CTGGAAGCACGAATGACAGA | 297 |
Reverse: TTTCAAGTTGGATGCATTGG | ||
TGF-β1 | Forward: CCAACTA TTGCTTCAGCTCCA | 154 |
Reverse: GTGTCCAGGCTCCAAATGT | ||
β-actin | Forward: CACCCGCGAGTACAACCTTC | 207 |
Reverse: CCCATACCCACCATCACACC |
GSK, glycogen synthase kinase; NF, nuclear factor; TGF, transforming growth factor.